The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Calithera Biosciences, Inc. | Common Stock | 13089P101 | 11,915 | 2,426,702 | SH | SOLE | 2,426,702 | 0 | 0 | ||
| Karyopharm, Inc. | Common Stock | 48576U106 | 35,031 | 2,263,006 | SH | SOLE | 2,263,006 | 0 | 0 | ||
| Mereo BioPharma Group PLC | ADS | 589492107 | 919 | 256,734 | SH | SOLE | 256,734 | 0 | 0 | ||
| Senseonics Holdings, Inc. | Common Stock | 81727U105 | 8,585 | 9,846,294 | SH | SOLE | 9,846,294 | 0 | 0 | ||
| Tandem Diabetes, Inc. | Common Stock | 875372203 | 95,680 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||